#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia chromosome positive Frostbite Retinitis pigmentosa Waldenstrom's macroglobulinaemia Heart disease congenital Granulomatosis with polyangiitis Chronic graft versus host disease Acute promyelocytic leukaemia Polycythaemia vera Head and neck cancer Isodicentric chromosome 15 syndrome Acromegaly Malignant melanoma Pancreatic neuroendocrine tumour Lymphangiosarcoma More trials…

    Learn about Rare Diseases

    Pulmonary sarcoidosis – Diagnostics Progressive multifocal leukoencephalopathy – Life with Disease Encephalitis autoimmune – Treatment Retinitis pigmentosa – Diagnostics Uterine leiomyosarcoma Systemic sclerosis pulmonary – Basic Information Pleural mesothelioma malignant – Basic Information Krabbe’s disease – Life with Disease KBG syndrome – Diagnostics Angiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Simoctocog Alfa Emactuzumab LUNSEKIMIG Tebipenem Pivoxil Hydrobromide Lithium Sulphate, Anhydrous Clazakizumab NADOFARAGENE FIRADENOVEC Codeine Phosphate Hemihydrate R3R01 ACETYLCARNITINE HYDROCHLORIDE Atropine Sulfate Nms-03305293 Mirikizumab Milnacipran Hydrochloride Ozanimod Hydrochloride Tryptophan Specific Nucleic Acid Sna-Ebv [18F]Alf-Nota-Octreotide Sarilumab Bidridistrogene Xeboparvovec More therapies…

    Learn about Your Condition

    Toxicity to various agents Organ donor Hereditary ataxia Anaplastic thyroid cancer Erythema multiforme Micrographic skin surgery Tympanic membrane hyperaemia Anaemia of pregnancy Cancer pain Obstructive airways disorder Prinzmetal angina Pseudomyxoma peritonei Inguinal hernia Osteoporosis postmenopausal Pulmonary fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on Reducing Dupilumab Dose for Patients with Controlled Atopic Eczema

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Dupilumab
    The Netherlands

  • Study of Lebrikizumab and Topical Corticosteroids for Children and Teens with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Eczema
    • Dermatitis atopic
    Investigated Drugs:
    • Agents For Dermatitis, Excluding Corticosteroids
    • Corticosteroids, Potent (Group Iii)
    • Corticosteroids, Very Potent (Group Iv)
    Czechia France Germany Poland Spain

  • Study on the Effects of Adalimumab and Saline in Patients Undergoing Needle Fasciotomy for Dupuytren’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dupuytren’s contracture
    Investigated Drugs:
    • Saline
    • Adalimumab
    Belgium

  • Study on the Safety of DS-2325a for Patients with Netherton Syndrome

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Netherton’s syndrome
    Investigated Drugs:
    • Ds-2325A
    • Sodium Chloride Solution 0.9%
    France

  • Study on the Tolerability and Effectiveness of Tirbanibulin for Patients with Actinic Cheilitis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Actinic cheilitis
    Investigated Drugs:
    • Tirbanibulin
    Germany

  • Study on the Effectiveness and Safety of DC-806 for Adults with Moderate to Severe Plaque Psoriasis

    Not recruiting

    2 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Dc-806
    Czechia Germany Hungary Poland Spain
Previous Page
1 … 60 61 62 63 64 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!